Compounds > prostratin

Page last updated: 2024-08-24

prostratin and HIV

prostratin has been researched along with HIV in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, L; Li, M; Lin, J; Pan, X; Zeng, X; Zhang, M; Zhao, W	1
DeChristopher, BA; Loy, BA; Marsden, MD; Schrier, AJ; Wender, PA; Zack, JA	1
Guo, J; Li, Z; Wu, Y; Zhou, Q	1
Brown, SJ; De Clercq, E; Fikkert, V; Hantson, A; Hezareh, M; Pannecouque, C; Van Remoortel, B; Witvrouw, M	1
Bisgrove, D; Chen, LF; Fenard, D; Greene, WC; Kwon, H; Verdin, E; Williams, SA	1
Alcamí, J; Beltán, M; Bermejo, M; Brown, SJ; García-Pérez, J; González, N; Hezareh, M; Rullas, J	1

Other Studies

6 other study(ies) available for prostratin and HIV

Article	Year
[Euphorbia fischeriana extract reactivates latent HIV through nuclear factor-κB pathway]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2015, Volume: 35, Issue:11 Topics: Euphorbia; Flow Cytometry; HIV; HIV Infections; Humans; NF-kappa B; Nitriles; Phorbol Esters; Plant Extracts; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha; Virus Latency	2015
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nature chemistry, 2012, Volume: 4, Issue:9 Topics: Animals; Anti-HIV Agents; Bryostatins; Cell Line; Chemical Engineering; Drug Design; HIV; Humans; Phorbol Esters; Protein Kinase C; Rats; Virus Activation	2012
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic acids research, 2013, Jan-07, Volume: 41, Issue:1 Topics: Anti-HIV Agents; Azepines; Cell Cycle Proteins; Cyclin-Dependent Kinase 9; HeLa Cells; HIV; Humans; Jurkat Cells; Nuclear Proteins; Phorbol Esters; Phosphorylation; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Ribonucleoproteins, Small Nuclear; RNA Polymerase II; tat Gene Products, Human Immunodeficiency Virus; Transcription Factors; Transcriptional Activation; Transcriptional Elongation Factors; Triazoles; Virus Latency	2013
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry. Antiviral chemistry & chemotherapy, 2003, Volume: 14, Issue:6 Topics: Cell Line; Genotype; HIV; HIV Envelope Protein gp160; Humans; Membrane Fusion; Phorbol Esters; Recombination, Genetic; Simian Immunodeficiency Virus	2003
Prostratin antagonizes HIV latency by activating NF-kappaB. The Journal of biological chemistry, 2004, Oct-01, Volume: 279, Issue:40 Topics: Active Transport, Cell Nucleus; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Viral; HIV; HIV Long Terminal Repeat; Humans; I-kappa B Kinase; Jurkat Cells; NF-kappa B; Phorbol Esters; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Virus Latency	2004
Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. Antiviral therapy, 2004, Volume: 9, Issue:4 Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; HIV; HIV Long Terminal Repeat; Humans; Leukocytes, Mononuclear; NF-kappa B; Phorbol Esters; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Time Factors; Transcriptional Activation; Transfection; Virus Activation	2004